Aedifica NV
XBRU:AED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aedifica NV
XBRU:AED
|
BE |
|
S
|
Sherwin-Williams Co
F:SJ3
|
US |
|
Regeneron Pharmaceuticals Inc
LSE:0R2M
|
US |
|
D
|
Delta Air Lines Inc
BMV:DAL
|
US |
|
MS&AD Insurance Group Holdings Inc
OTC:MSADY
|
JP |
|
G
|
General Mills Inc
XMUN:GRM
|
US |
|
N
|
Nextera Energy Inc
DUS:FP3
|
US |
|
SITC International Holdings Co Ltd
F:7S8
|
HK |
|
E
|
Equifax Inc
F:EFX
|
US |
|
Celestica Inc
F:CTW0
|
CA |
|
C
|
Charles Schwab Corp
XMUN:SWG
|
US |
Wall St Price Targets
AED Price Targets Summary
Aedifica NV
According to Wall Street analysts, the average 1-year price target for AED is 82.99 EUR with a low forecast of 70.7 EUR and a high forecast of 98.7 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AED's stock price target?
Price Target
82.99
EUR
According to Wall Street analysts, the average 1-year price target for AED is 82.99 EUR with a low forecast of 70.7 EUR and a high forecast of 98.7 EUR.
What is the Revenue forecast for Aedifica NV?
Projected CAGR
16%
Over the last 4 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 16%.
What is the Operating Income forecast for Aedifica NV?
Projected CAGR
16%
Over the last 4 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 16%.
What is the Pre-Tax Income forecast for Aedifica NV?
Projected CAGR
14%
Over the last 4 years, the compound annual growth rate for Pre-Tax Income has been -4%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Aedifica NV?
Projected CAGR
16%
Over the last 4 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 3 years is 16%.
